Clinical trial

Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer

NCT01419717

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-11-22

PhasePHASE3

Study timeline

Study start (actual)2011-11-22Date precision: day

Registry last updated2019-09-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Bone Metastases in Men With Hormone-Refractory Prostate Cancerunresolved

Bone Metastases in Subjects With Advanced Breast Cancerunresolved

Interventions

DenosumabDRUG · verified · RxNorm: denosumab

Sponsors & collaborators

Amgenlead sponsor

Mapped research locations

PragueCzechia4 São PauloSão Paulo, Brazil3 MadridSpain2 Porto AlegreRio Grande do Sul, Brazil2 Rio de JaneiroBrazil2 LimaPeru2 MoscowRussia1 WarsawPoland1 Saint PetersburgRussia1 ViennaAustria1 São PauloBrazil1 PoznanPoland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01419717 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.